Vaccine Development: Strategic Approach & Response During Pandemics

Over the past decade, outbreaks of H1N1 influenza, Sars-Cov, Ebola, and MERS have sparked ongoing conversations about strategic approaches and responses to pandemics and epidemics. Now with the spread of SARS-CoV-2 intensifying, scientists, together with pharmaceutical companies, are reinventing the approach of how to bring these life-saving drugs to market faster without impacting product quality, safety, or efficacy. 

Watch this on-demand webinar to learn about:

• Bringing life-saving drugs to market faster without impacting product quality, safety, or efficacy
• Impacts and comparisons of classic platforms vs new-generation platforms 
• Establishing a new and proactive approach to managing the unpredictable demand of life-saving products